Keywords: merck, co, vioxx, get, fda, review, april

Merck & Co's Vioxx to get FDA review in April

Article | 04 March 1999

Print This

Merck & Co's New Drug Application to the US Food and Drug Administrationfor approval of Vioxx (rofecoxib) will be reviewed by ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in